Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
You may find that fatty and sugary foods become less attractive and portion control gets easier
Many patients find tirzepatide's appetite suppression 'teaches' their brain what true fullness feels like, making healthy eating easier even after treatment ends
As T2D is often associated with having a high body mass index, one would be forgiven for assuming that the needs of people who use GLP-1s for weight loss and those using it to treat diabetes would be very similar, but recent market research suggests a number of significant differences:5 The majority of people using GLP-1s for weight loss are in their 30s to 50s (often as part of a wider strategy to be proactive about their health), whereas those using GLP-1s for diabetes control are more likely to be over 60
Don't just resume at the same level
The mean unweighted follow-up time was 9.9 months in the semaglutide group and 11.2 months in the DPP-4i group
Call 318-232-4404 or schedule online today.
